NDCFind

Galcanezumab-Gnlm 00002-2377-00

Package NDC

00002-2377-00

Product NDC: 00002-2377

Manufacturer
Eli Lilly And Company
Dosage Form
Injection, Solution
Product Type
Drug For Further Processing
Marketing Start
September 27, 2018
Listing Expires
December 31, 2026

Active Ingredients

IngredientStrength
Galcanezumab120 mg/mL

Selected Package

00002-2377-00Selected

1 mL in 1 SYRINGE (0002-2377-00)